2016 annual financial data
Sutro Biopharma 2016 Net margin
Direct answer
Net margin was 2.85%.
Operating income was 1.36M USD and net income was 1.7M USD.
Operating cash flow was -13.15M USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 59.73M USD
- Operating income
- 1.36M USD
- Net income
- 1.7M USD
- Operating cash flow
- -13.15M USD